Cellular FLICE-inhibitory protein (c-FLIP) signalling: A key regulator of receptor-mediated apoptosis in physiologic context and in cancer |
| |
| Authors: | Marina Bagnoli Silvana Canevari Delia Mezzanzanica |
| |
| Institution: | 1. Center for Stem Cell Therapeutics and Imaging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02129, USA;2. Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02129, USA;3. Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA |
| |
| Abstract: | Cellular FLICE-inhibitory protein (c-FLIP) is a catalytically inactive procaspase-8/10 homologue that associates with the signalling complex downstream of death-receptors negatively interfering with apoptotic signalling. Three c-FLIP splice variants have been identified: c-FLIPL, c-FLIPS and c-FLIPR, with all three functioning as apoptosis inhibitors involved in modulation of caspase-8/10 activity in both physiologic and pathologic contexts. Furthermore, a cell-type specific pro-apoptotic role, depending on caspase-8 to c-FLIPL ratio, has also been described for the long isoform. The present review summarizes recent findings concerning c-FLIP proteins’ function and regulation, with a main focus on the c-FLIPL deregulated expression in cancer. The role of c-FLIPL as anti-apoptotic pro-survival factor in tumors and the potential utility of this molecule as a possible alternative therapeutic target are discussed. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
